Deregulation of MTDH gene expression in gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2833-2836

  Baygi, Modjtaba Emadi ^a   Nikpour, Parvaneh ^b  

^a SHAHREKORD UNIVERSITY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AEG 1; Gastric cancer; Gene expression; MTDH

Indexed keywords

EID: 84874097138     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2833     Document Type: Article

References (30)

1. Buckland P R (2004). Allele-specific gene expression differences in humans. Hum Mol Genet, 13, 255-60.
2. Chen X, Leung S Y, Yuen S T, et al (2003). Variation in gene expression patterns in human gastric cancers. Mol Biol Cell, 14, 3208-15.
3. Emdad L, Sarkar D, Su Z Z, et al (2007). Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther, 114, 155-70.
4. Emdad L, Sarkar D, Su Z Z, et al (2006). Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res, 66, 1509-16.
5. Jian-bo X, Hui W, Yu-long H, et al (2010). Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol, 28, 455-62.
6. Keeney S, Bauer T L (2006). Epidemiology of adenocarcinoma of the esophagogastric junction. Surgical Oncology clinics of North Am, 15, 687-96.
7. Kikuno N, Shiina H, Urakami S, et al (2007). Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 26, 7647-55.
8. Kim D H, Mohapatra G, Bollen A, Waldman F M, Feuerstein B G (1995). Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer, 60, 812-9.
9. Lee S G, Jeon H Y, Su Z Z, et al (2009). Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene, 28, 2476-84.
10. Lee S G, Su Z Z, Emdad L, Sarkar D, Fisher P B (2006). Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA, 103, 17390-5.
11. Lee S G, Su Z Z, Emdad L, et al (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene, 27, 1114-21.
12. Li J, Yang L, Song L, et al (2009). Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene, 28, 3188-96.
13. Li J, Zhang N, Song L B, et al (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res, 14, 3319-26.
14. Li X, Kong X, Huo Q, et al (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci, 102, 1151-7.
15. Liu L, Wu J, Ying Z, et al (2010). Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res, 70, 3750-9.
16. Malekzadeh R, Derakhshan M H, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
17. Mowla S J, Emadi Bayegi M, Ziaee S A, Nikpoor P (2005). Evaluating expression and potential diagnostic and prognostic values of Survivin in bladder tumors: a preliminary report. Urology J, 2, 141-7.
18. Nikpour P, Mowla S J, Jafarnejad S M, Fischer U, Schulz W A (2009). Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Proliferation, 42, 762-9.
19. Ooi C H, Ivanova T, Wu J, et al (2009). Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet, 5, 1000676.
20. Poon T C, Wong N, Lai P B, et al (2006). A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. Gastroenterology, 131, 1262-70.
21. Santarpia M, Magri I, Sanchez-Ronco M, et al (2011). mRNA expression levels and genetic status of genes involved in the EGFR and NF-kappaB pathways in metastatic non-small-cell lung cancer patients. J Transl Med, 9, 163.
22. Sarkar D, Emdad L, Lee S G, et al (2009). Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res, 69, 8529-35.
23. Sarkar D, Park E S, Emdad L, et al (2008). Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res, 68, 1478-84.
24. Song H, Li C, Li R, Geng J (2010). Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis, 25, 1201-9.
25. Song L, Li W, Zhang H, et al (2009). Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol, 219, 317-26.
26. The National Cancer Registry (2008). Fourth national report on cancer incidence and mortality. Ministry of Health and Medical Education, Tehran, Iran.
27. Thirkettle H J, Girling J, Warren A Y, et al (2009). LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res, 15, 3003-13.
28. Wang Y, Klijn J G, Zhang Y, et al (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365, 671-9.
29. Yoo B K, Emdad L, Su Z Z, et al (2009). Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest, 119, 465-77.
30. Yu C, Chen K, Zheng H, et al (2009). Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis, 30, 894-901.